Emily M. Leproust sold $923k of TWST
Chief Executive Officer at Twist Bioscience Corp. 5,203 shares at an average of $177.38, traded Sep 24, 2026, filed Sep 25, 2026.
Score components
- +25RoleCEO
- +24Trade size$923k at market
- 0Share of holdings soldSold 0.8% of holdings
- +15Cluster6 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001214659-26-011980, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | SOpen-market sale Common Stock10b5-1 | -2,485 | $175.23 | $435k | 616,417 | 17 d ago |
| Sep 24, 2026 | SOpen-market sale Common Stock10b5-1 | -945 | $176.39 | $167k | 615,472 | 17 d ago |
| Sep 24, 2026 | SOpen-market sale Common Stock10b5-1 | -164 | $177.17 | $29k | 615,308 | 17 d ago |
| Sep 24, 2026 | SOpen-market sale Common Stock10b5-1 | -330 | $178.67 | $59k | 614,978 | 17 d ago |
| Sep 24, 2026 | SOpen-market sale Common Stock10b5-1 | -143 | $179.93 | $26k | 614,835 | 17 d ago |
| Sep 24, 2026 | SOpen-market sale Common Stock10b5-1 | -515 | $180.39 | $93k | 614,320 | 17 d ago |
| Sep 24, 2026 | SOpen-market sale Common Stock10b5-1 | -21 | $181.45 | $3,810 | 614,299 | 17 d ago |
| Sep 24, 2026 | SOpen-market sale Common Stock10b5-1 | -16 | $182.50 | $2,920 | 614,283 | 17 d ago |
| Sep 24, 2026 | SOpen-market sale Common Stock10b5-1 | -501 | $183.76 | $92k | 613,782 | 17 d ago |
| Sep 24, 2026 | SOpen-market sale Common Stock10b5-1 | -83 | $184.60 | $15k | 613,699 | 17 d ago |
Related signals
Other insiders at Twist Bioscience Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 44Moderate | Twist Bioscience Corp | Emily M. Leproust Chief Executive Officer | $919k 4,548 shares | -1% | |
| 60Notable | Twist Bioscience Corp | Dennis Cho See Remarks | $1.8M 9,514 shares | -13% | |
| 65Notable | Twist Bioscience Corp | Patrick John Finn President and COO | $4.9M 25,714 shares | -12% | |
| 55Moderate | Twist Bioscience Corp | Paula Green SVP of Human Resources | $1.9M 10,088 shares | -9% | |
| 62Notable | Twist Bioscience Corp | Adam Laponis Chief Financial Officer | $1.5M 8,057 shares | -7% | |
| 45Moderate | Twist Bioscience Corp | Emily M. Leproust Chief Executive Officer | $8.8M 46,391 shares | -8% | |
| 44Moderate | Twist Bioscience Corp | Robert F. Werner Chief Accounting Officer | $280k 1,482 shares | -3% | |
| 37Weak | Twist Bioscience Corp | Dennis Cho See Remarks | $58k 348 shares | -0% | |
| 37Weak | Twist Bioscience Corp | Paula Green SVP of Human Resources | $49k 294 shares | -0% | |
| 54Moderate | Twist Bioscience Corp | Emily M. Leproust Chief Executive Officer | $279k 1,687 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.